Product name | Recombinant Human CCL2/MCP-1 Protein |
---|---|
Catalog No. | RP01411 |
Description | Recombinant Human CCL2/MCP-1 Protein is produced by E. coli expression system. The target protein is expressed with sequence (Gln24-Thr99) of human CCL2/MCP-1 (Accession #NP_002973.1) fused with no additional amino acid. |
Bio-Activity | 1.Measured by the ability to inhibit the proliferation of HUVEC(Human Umbilical Vein Endothelial Cells).The ED50 for this effect is 0.53-2.12 ng/mL. 2.Measured by its ability to chemoattract THP-1 cells. The ED50 for this effect is typically 1.01-4.04 ng/mL. |
Purity | > 90% by SDS-PAGE. |
Endotoxin | <1EU/μg |
Formulation | Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4. |
Species | Human |
Calculated MW | 8.69 kDa |
Synonym | CCL2; GDCF-2; HC11; HSMCR30; MCAF; MCP-1; MCP1; SCYA2; SMC-CF |
---|---|
Expression Host | E. coli |
Tag | No tag |
Swiss-Prot | |
Gene ID |
Storage | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
---|---|
Reconstitution | Centrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles. |
* For research use only. Not for therapeutic or diagnostic purposes.